PetLife Pharmaceuticals, Inc. Research and Development Expense
PetLife Pharmaceuticals, Inc. reported Research and Development Expense of $0 for the 12-month period ending 2016-08-31, per its 10-K filed 2016-12-21.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2016-12-21
- PetLife Pharmaceuticals, Inc. research and development expense for the quarter ending 2015-05-31 was $0.00, a 100.00% decline year-over-year.
- PetLife Pharmaceuticals, Inc. research and development expense for the quarter ending 2015-02-28 was -$92.60K, a 544.84% decline year-over-year.
- PetLife Pharmaceuticals, Inc. research and development expense for the quarter ending 2014-08-31 was $15.71K.
- PetLife Pharmaceuticals, Inc. research and development expense for the quarter ending 2014-05-31 was $36.67K.
- PetLife Pharmaceuticals, Inc. research and development expense for fiscal 2016 was $0.00.
- PetLife Pharmaceuticals, Inc. research and development expense for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- PetLife Pharmaceuticals, Inc. research and development expense for fiscal 2014 was $73.20K.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month | Research and Development Expense 21 month | Research and Development Expense 24 month | Research and Development Expense 27 month | Research and Development Expense 30 month |
|---|---|---|---|---|---|---|---|---|
| 2016-08-31 | $0.00 10-K · filed 2016-12-21 | |||||||
| 2015-08-31 | $0.00 10-K · filed 2016-12-21 | |||||||
| 2015-05-31 | $0.00 derived: 10-Q 30 month − 10-Q 27 month · filed 2015-12-31 | -$92.60K derived: sum of 2 quarters · filed 2015-12-31 | $73.20K 10-Q · filed 2015-12-31 | |||||
| 2015-02-28 | -$92.60K derived: 10-Q 27 month − 10-Q 24 month · filed 2015-12-31 | $73.20K 10-Q · filed 2015-12-31 | ||||||
| 2014-11-30 | $165.80K 10-Q · filed 2015-12-31 | |||||||
| 2014-08-31 | $15.71K derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-01-06 | $52.38K derived: sum of 2 quarters · filed 2016-01-06 | $73.20K derived: sum of 3 quarters · filed 2016-01-06 | $73.20K 10-K/A · filed 2016-01-06 | $73.20K 10-K · filed 2015-12-31 | |||
| 2014-05-31 | $36.67K 10-Q · filed 2015-12-31 | $57.49K derived: sum of 2 quarters · filed 2015-12-31 | $57.49K 10-Q · filed 2015-12-31 | |||||
| 2014-02-28 | $20.82K 10-Q · filed 2015-12-31 | $20.82K 10-Q · filed 2015-12-31 | ||||||
| 2013-08-31 | $0.00 10-K · filed 2015-12-31 |